EARNEST Partners’s Tenet Healthcare THC Stock Holding History

EARNEST Partners’s Portfolio THC Stock Details THC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-29	Closed	–	–	830
2016 Q4	$0	Buy	+29	New	+$520	﹤0.01%	1169

Other funds holding THC

GCM

Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

LCOV

London Company of Virginia Richmond, Virginia $17.5B AUM 29.92% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

EARNEST Partners's THC Position: Q1 2017 in Review

EARNEST Partners sold out of Tenet Healthcare (THC) in Q1 2017, closing a stake of 29 shares.

EARNEST Partners first reported a position in THC in Q4 2016 and held it in 1 quarter. The position peaked at $0 in Q4 2016. 252 funds tracked by Wall St. Rank hold THC as of Q1 2017.

EARNEST Partners reported no remaining Tenet Healthcare position as of Q1 2017 after selling out during the quarter.
EARNEST Partners sold 29 Tenet Healthcare shares in Q1 2017.
EARNEST Partners first reported a position in Tenet Healthcare in Q4 2016 and held it in 1 quarter.
EARNEST Partners's Tenet Healthcare position peaked at $0 in Q4 2016.
252 funds tracked by Wall St. Rank held Tenet Healthcare as of Q1 2017.

Based on EARNEST Partners's 13F filing for Q1 2017, filed 15 May 2017.